Results
1 -
9 of
9
(Click
here to explore results)
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Biosynthetic characterization of the antifungal fernane-type triterpenoid polytolypin for generation of new analogues via combinatorial biosynthesis. Xin-Yu Li, Jian-Ming Lv, Zhi-Qin Cao, Gao-Qian Wang, Fu-Long Lin, Guo-Dong Chen, Sheng-Ying Qin, Dan Hu, Hao Gao, Xin-Sheng Yao
, Org. Biomol. Chem.
, 2023
, 21
, 851
- Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections. Jayapradha Ramakrishnan, Sudarshan Singh Rathore, Thiagarajan Raman
, RSC Adv.
, 2016
, 6
, 42387
- A complex game of hide and seek: the search for new antifungals. Huy X. Ngo, Sylvie Garneau-Tsodikova, Keith D. Green
, Med. Chem. Commun.
, 2016
, 7
, 1285
- Modulation of plant chemistry by beneficial root microbiota. Desalegn W. Etalo, Je-Seung Jeon, Jos M. Raaijmakers
, Nat. Prod. Rep.
, 2018
, 35
, 398
- Enzymes in preparative mono- and oligo-saccharide synthesis. Chris J. Hamilton
, Nat. Prod. Rep.
, 2004
, 21
, 365
- Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases. Lauren Tedaldi, Gerd K. Wagner
, Med. Chem. Commun.
, 2014
, 5
, 1106
- Triterpenoids. Joseph D. Connolly, Robert A. Hill
, Nat. Prod. Rep.
, 2002
, 19
, 494
- Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study. James M. Balkovec, David L. Hughes, Prakash S. Masurekar, Carole A. Sable, Robert E. Schwartz, Sheo B. Singh
, Nat. Prod. Rep.
, 2014
, 31
, 15